SC

Sudipta Chattopadhyay

Active Director Director DIN 08721831
DIN 08721831 First appointment Mar 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since Mar 2020
Shareholding value •••• Premium profile

About Sudipta Chattopadhyay

Data last updated:

Sudipta Chattopadhyay is a Director at Esperer Onco Nutrition Private Limited (since 2023), Director at Esperer Bio-Research Private Limited (since 2020) and Director at Health Voitho Technologies Private Limited (since 2021). The companies operate in Healthcare and Machinery and Equipment. The 3 current companies with reported revenue have a combined latest revenue of ₹6.99 Cr; the largest is Esperer Onco Nutrition Private Limited at ₹5.32 Cr (FY 2025).

DIN 08721831
Primary Designation Director
Industry Healthcare
First Appointment 12 Mar 2020
Oldest Company Age 8 yrs
Largest company Esperer Onco Nutrition Private Limited · ₹5.32 Cr (FY 2025)
Combined revenue ₹6.99 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Dec 20232019₹5.32 Cr (FY 2025)Active
Esperer Bio-Research Private Limited U24304MH2018PTC312841
Director12 Mar 20202018₹1.57 Cr (FY 2024)Active
Director01 Mar 20212019₹10 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Esperer Bio-Research Private Limited
Health Voitho Technologies Private Limited
Esperer Onco Nutrition Private Limited
Premium access

Shareholding and investment profile for Sudipta Chattopadhyay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudipta Chattopadhyay

Sudipta Chattopadhyay currently holds 3 directorships: Esperer Onco Nutrition Private Limited (Director, since 20 Dec 2023, revenue ₹5.32 Cr (FY 2025)); Esperer Bio-Research Private Limited (Director, since 12 Mar 2020, revenue ₹1.57 Cr (FY 2024)); Health Voitho Technologies Private Limited (Director, since 01 Mar 2021, revenue ₹10 Lakh (FY 2025)).

Sudipta Chattopadhyay was first appointed on 12 Mar 2020 as Director at Esperer Bio-Research Private Limited. The most recent appointment on record is 20 Dec 2023 at Esperer Onco Nutrition Private Limited.

The 3 current companies of Sudipta Chattopadhyay that report revenue have a combined latest revenue of ₹6.99 Cr: Esperer Onco Nutrition Private Limited ₹5.32 Cr (FY 2025); Esperer Bio-Research Private Limited ₹1.57 Cr (FY 2024); Health Voitho Technologies Private Limited ₹10 Lakh (FY 2025).

The current boards of Sudipta Chattopadhyay's companies include Raktim Chattopadhyay (Esperer Onco Nutrition Private Limited), Raktim Chattopadhyay (Esperer Onco Nutrition Private Limited), Riddhesh Neema (Esperer Onco Nutrition Private Limited), Sohilkumar Dahyabhai Tandel (Esperer Onco Nutrition Private Limited), Shubhankar Karmakar (Esperer Bio-Research Private Limited), Venkataktyayani Sushmitha Gorantla (Esperer Bio-Research Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available